Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Progyny Sees Q4 2023 Revenue $268.3M-$276M Vs $274.23M Est

Author: Benzinga Newsdesk | November 07, 2023 05:42pm
  • Fourth Quarter of 2023 Outlook:
    • Revenue is projected to be $268.3 million to $276.3 million, reflecting growth of 25% to 29%
    • Net income is projected to be $9.7 million to $11.4 million, or $0.10 to $0.11 per diluted share, on the basis of approximately 102 million assumed weighted-average fully diluted-shares outstanding
    • Adjusted EBITDA1 is projected to be $42.2 million to $44.7 million

Posted In: PGNY

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist